The Motley Fool Take

Good medicine for Johnson & Johnson, X doesn't mark the spot for Microsoft, and the housewarming may be over for the housing market. Tom and David Gardner give the Motley Fool Take on some of the week's big business stories, and a few other stories that showed up on the Fool radar.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.